INTRODUCTION
Liver is a vital and major metabolic organ repeatedly exposed to various drugs, chemicals, and toxins by virtue of our lifestyle activities. It is essential to protect liver by using a successful hepatoprotective agent. Owing to the absence of effective liver protective drugs in allopathic medicine, herbal drugs and extracts play an important role in the management of liver disorders. The model of isoproterenol (ISO)-induced myocardial infarction (MI) is considered as one of the most widely used experimental model to study the benefi cial effects of many drugs and cardiac function. [1] ISO is a synthetic catecholamine and β-adrenergic agonist, which causes severe oxidative stress, resulting in infarct like necrosis. It is structurally similar to epinephrine [adrenaline-[ Figure 1 ] and acts selectively on β-receptors. [2] Enhanced free radical (FR) formation and lipid peroxide accumulation have been proposed as one of the possible biochemical mechanisms for damage during ISO administration [3] MI produces signifi cant abnormal liver functioning. [4] Liver is often affected by various drugs and pollutants, which can damage and weaken it eventually leading to hepatitis or cirrhosis. [5] Due to several undesirable effects of synthetic drugs, the world population is moving toward medicines derived from locally available native extracts of edible plant parts and plants products. Nutmeg is the dried seed kernel of Myristica fragrans (family: Myristicaceae), an evergreen aromatic tree cultivated in many tropical countries and is widely used as a spice and also to fl avor many kinds of baked foods and vegetables. Recent studies indicate that nutmeg is useful against damage caused by gamma radiation and also in the improvement of mouse memory. [6, 7] Anti-infl ammatory activity of nutmeg has also been reported in addition to its insulin-like biological activity. [8, 9] Nutmeg has been reported to possess cardio tonic property in the ancient and traditional system of Indian medicine, which prompted us to select the nutmeg aqueous extract (NMAET) to treat hepatotoxicity associated with ISO-induced oxidative stress. In a recent study antihyperglycemic and hyperlipidemia activities of NMAET were proven. [10] The aim of present study is to evaluate the hepatoprotective effect of NMAET against ISO-induced oxidative stress. Adding up to this lipid peroxidation (LPO) and liver histopathology were examined to assess the protective effect of NMAET in ISO-induced hepatotoxicity.
MATERIALS AND METHODS

Chemicals
ISO was purchased from Sigma-Aldrich (USA). All other chemicals were of analytical grade and were supplied by Sisco Research Laboratories (Mumbai, India).
Animal ethical committee approval
The groups include control, NMAET treatment, NMAET pretreatment, and ISO administered were done with the approval of institutional animal ethic committee (Regd. No. 470/01/a/CPCSEA, dated 24 th Aug 2001) and as per guidelines.
Plant material
Fresh nutmegs (500 g) were procured from local market. Nutmeg was verified with specimens available at the botanical herbarium of the University. They were air dried and powdered in an electric blender. The powder was boiled in distilled water. After fi ltration through Whatmann No. 40 fi lter paper, the extract was evaporated to dryness by slow heating and continuous stirring in a water bath. The dark brown residue left behind was collected and was used for studies.
Experimental induction of oxidative stress
Adult male rats of Wistar strain weighing 120-150 g were procured from National Centre for Animal Science, National Institute of Nutrition, Hyderabad, India. Animals were housed under standard laboratory conditions with relative humidity 65% ±2%, temperature 23°C ± 2°C and 12:12 h light: dark cycle. They were fed with standard rodent pellet diet (M/s. Hindustan Lever Ltd., Mumbai, India) and water ad libitum. After acclimatization for a month, the rats were divided into four groups of eight animals in each and caged individually. Oxidative stress was induced by subcutaneous (s.c.), injection of ISO 85 mg/kg body weight (BW), dissolved in physiological saline (0.2 mL), twice at an interval of 24 h for 2 days. [11] 
Experimental design
Control-Rats fed with standard rodent pellet diet and received physiological saline s.c. for 2 days after 30 days experimental period. ISO administered-Rats fed with standard rodent pellet diet and administered ISO at a dose of 85 mg/kg BW, s.c., dissolved in physiological saline twice at an interval of 24 h for 2 days. NMAET Treatment-Rats fed with standard rodent pellet diet and treated with NMAET orally (100 mg/kg BW/day for a period of 30 days). NMAET pretreatment-Rats fed with standard rodent pellet diet and treated with NMAET orally (100 mg/kg BW/day for a period of 30 days) and then ISO at the dose mentioned for ISO-administered group.
The extract dose used in this study was fi xed based on the acute oral toxicity study as well as reports published on the biological effects of M. fragrans (nutmeg) extract. [8] Extract treated and extract pretreated animals received the extract orally by gastric tube, every day in between 8 and9 am for a period of 30 days.
Collection of sample and preparation of tissue
At the end of experimental period the animals were fasted for 12 h to minimize dietary infl uences and sacrifi ced around 8 am by cervical dislocation. Blood was drawn by cardiac puncture in sterile syringes and then transferred in to Eppendorf tubes containing heparin. Plasma was separated from cells by centrifugation at 3000 rpm for 10 min. A small portion of liver tissue was removed, washed thoroughly with ice-cold saline, and suspended in formalin buffer for histological examinations in polypropylene containers. A total of 100 mg of wet heart tissue was weighed accurately and homogenized in 5 mL of 0.1 M Tris-HCl buffer (pH 7.4) in ice-cold condition. The homogenate was centrifuged at 2500 g and the clear supernatant was taken for the assay of antioxidant and cardiac marker enzymes along with LPO. From the heart tissue lipids were extracted by the method of Folch et al. [12] Acute oral toxicity and LD50 Acute oral toxicity study was performed for NMAET as per OECD-423 guidelines using adult male albino rats of Wistar strain. [13] The animals were fasted for overnight prior to the experiment and maintained under standard conditions. NMAET extract was administered orally in increasing dose and found safe up to 1000 mg/kg body weight. The animals were observed for toxic symptoms such as locomotion, convulsions, behavioral changes, and mortality for 72 h. NMAET showed no lethal effect at least up to a dose of 1000 mg/kg body weight indicating that LD50 if any should be higher than this dose.
In vitro free radical scavenging studies
The in vitro FR scavenging activity of the extract was measured in terms of hydrogen donating or radical scavenging ability using the stable radical 1,1-diphenyl-2-picrylhydrazyl (DPPH), [14] different concentrations of extract (50-600 μg) in 0.3 mL of distilled water was mixed with 2.7 mL of DPPH solution and shaken vigorously and allowed to stand at room temperature for 30 min. Systems devoid of extract were considered as control. The absorbance was measured at 517 nm. The FR scavenging capacity was determined by comparing the absorbance of treatment with that of the control where as the inhibition of LPO by the method of Sujioka et al. [15] The reaction mixture containing 1.0 mL of rat heart homogenate, 0.3 mL of ferric chloride, 0.3 mL of ADP-Na 2 , 0.4 mL of ascorbic acid, 0.2 mL of extract with different concentrations (150-3000 μg) and 0.8 mL of KCl was incubated for 20 min at 37°C. A system with distilled water, devoid of extract served as control. A total of 1 mL from each of test and control were treated with 4.0 mL of Thiobarbutyric acid, 2.0 mL of Trichloroacetic acid and heated in a boiling water bath for 30 min. After cooling, the absorbance of supernatant was read at 535 nm and the per cent inhibition of LPO was determined by comparing with control.
Measurement of liver function enzymes
Marker enzyme activities were assayed in both plasma and heart tissue homogenate by using the following methods. The activity of lactate dehydrogenase (LDH) was measured by the method of Teitz. [16] Creatinine kinase (CK) was assayed by the procedure of Henry, [17] Aspartate transaminase (AST) was determined by the method of Reitman and Frankel, [18] Alanine transaminase (ALT) was determined by the method of Reitman and Frankel, [18] Alkaline phosphotase (ALP) was determined by the procedure of Teitz, [16] γ-glutamyl transferase was assayed by the method of Rosalki and Tarlow. [19] 
Measurement of antioxidant status
The amount of glutathione (GSH) in the heart tissue homogenate was assayed by Ellmans method, [20] values are expressed as μg GSH/mg protein. GSH-dependent heart tissue antioxidant enzyme glutathione peroxidase (GPX) was measured by Rotruck et al., method, [21] the activity was expressed as μgm of GSH consumed/min/mg protein.
The activity of glutathione-S-transferase (GST) was measured by Habig et al., method, [22] expressed as mmoles of CDNB-GSH conjugate formed/min/mg protein. The activity of superoxide dismutase (SOD) was estimated by the method of Soon and Tan, [23] the specifi c activity was expressed as units/min/mg protein. Catalase (CAT) activity was assayed by Chance method, [24] the activity was expressed as mmoles of H 2 O 2 decomposed/min/mg protein. LPO was estimated in terms of thiobarbuturic acid reactive species using malondialdehyde as standard by the method of Ohkawa et al. [25] Hepatotoxicity studies Liver tissue histological analysis was carried out by method of Raghuramulu et al., [26] briefl y tissue fi xation was done immediately after removal from the body with 10% neutral buffered formaldehyde solution (pH 7.0). Tissue processing carried out at specifi c time intervals with desired solutions for dehydration, clearing and paraffi n infi ltration. The container was then fi lled with melted paraffi n and allowed to cool so that it can form block of paraffi n with the tissue. The block was trimmed so that to remove the excess paraffi n overlaying the piece of tissue, the sections were cut at 5 μm thickness and was mounted on clean glass slides, which had been smeared with a drop of Mayer's egg albumin. It was then dried on a hot plate at about 50°C for 30 min. The sections on the slides were then subjected to staining with hematoxylin and eosin.
Statistical analysis
Statistical analysis was performed by using one-way analysis of variance followed by Duncan's multiple range test. Results were expressed as mean ± standard error of mean for eight rats in each group. A value of P < 0.05 was considered statistically signifi cant.
RESULTS
According to oral toxicity studies the NMAET did not cause any mortality up to 1000 mg/kg and considered as safe. No lethality or any toxic reactions were found up to the end of the study period. Data presented in Table 1 illustrates a signifi cant decrease in the concentration of DPPH radical and inhibit the formation of lipid peroxides induced by Fe 3 +/ADP/ascorbate system [ Table 1 ].
NMAET treatment per se did not alter the activities of cardiac and liver marker enzymes like LDH, CK, AST, ALT, ALP, and GGT when compared to control [ Table 2 ]. In ISO administered rats, a signifi cant (P < 0.05) elevation in the activities of these marker enzymes was observed by 64.74%, 68.45%, 88.55%, 91.60%, 232%, and 46%, control, ISO administered treated and pretreated rat groups. ISO administration alone showed a signifi cant (P < 0.05) decrease in the activities of LDH, CK, AST, ALT, ALP, and GGT by 44.03%, 38.90%, 43.54%, 30.24%, 55.3%, and 47.9%, respectively when compared to control. Pretreatment of rats with NMAET signifi cantly (P < 0.05) increased the level of these marker enzymes by 56%, 44.44%, 55.2%, 21.87%, 52.38%, and 66.52%, respectively for LDH, CK, AST, ALT, ALP, and GGT compared to ISO administered rats [ Table 3 ].
Data presented in Table 4 indicate the levels of GSH and activities of GSH-dependent antioxidant enzymes (GPX and GST) and antiperoxidative enzymes (SOD, CAT) in the heart tissue and changes in LPO levels in the heart and plasma [ Table 4 ] of control and experimental rats. There is a signifi cant (P < 0.05) decrease in the level of GSH (49.90%) and activities of GSH-dependent enzymes, GPX and GST by 35.18% and 43%, respectively in the heart tissue. Further it is observed that signifi cant (P < 0.05) decrease in the activities of antiperoxidative enzymes, SOD, CAT by 32.17, 52.48%, respectively in the heart tissue noted along with a concomitant increase in the LPO in the heart tissue as well respectively, when compared to control. The activities of marker enzymes were signifi cantly (P < 0.05) reduced by 35.19%, 24.87%, 32.80%, 39.42%, 56.64%, and 21.62% for LDH, CK, AST, ALT, ALP, and GGT, respectively in pretreated group compared to ISO administered group [ Table 2 ]. Table 3 shows the activities of marker enzymes such as LDH, CK, AST, ALT, ALP, and GGT in the heart tissue of as in plasma by 73.55% and 70.41%, respectively occurred in ISO administered rats as compared to controls [ Table 4 ].
Treatment with NMAET alone increased the activities of antioxidant enzymes by 8.51%, 6.34%, 8.29%, and 6.73%, respectively for GPX, GST, SOD, and CAT along with GSH (13.71%). NMAET treatment also prevented the increase in LPO levels by 5.76% and 5.47% in heart tissue and plasma [ Figure 2 ]. However, NMAET treatment alone induced a signifi cant increase in myocardial antioxidant enzyme activities when compared with the control group. The pronounced oxidative stress effect of ISO is signifi cantly (P < 0.05) attenuated by pretreatment of animals with NMAET by 29.57%, 53.62%, 27.61%, 93.50%, and 53.77%, respectively for GPX, GST, SOD, CAT, and GSH along with LPO decrease in heart tissue and plasma by 37.89% and 16.72%, respectively. However, NMAET treatment alone induced a signifi cant increase in myocardial antioxidant enzyme activities as compared with the control group. The pronounced oxidative stress effect of ISO is signifi cantly attenuated in animals treated with NMAET [ Figure 2 ].
The liver sections [ Figure 3 ] of ISO administered rats showed massive fatty changes, necrosis, ballooning degeneration, and broad infi ltration of the lymphocytes and the loss of cellular boundaries. The histological architecture of liver sections of NMAET treated rats showed lobular pattern with a mild degree of fatty change and lymphocyte infi ltration almost similar to that of control. There is minimal damage, with mild swelling of hepatic cells was seen in NMAET pretreated rats. Thus, NMAET pretreatment retained near normal architecture of the liver when compared with ISO administered group [ Figure 3 ].
DISCUSSION
When myocardial cells containing LDH, CK, AST, ALT, ALP, and GGT are damaged or destroyed due to defi cient oxygen supply or glucose, the cell membrane becomes abnormally permeable or may rupture, which results in the leakage of enzymes. [27] ISO administration in rats causes gross, microscopic myocardial necrosis, and depletion of tissue enzymes in heart and liver. As a result of necrosis and leakage, the levels of diagnostic indicators of MI and hepatotoxicity, such as LDH, CK, AST, ALT, ALP, and GGT will increase [ Table 2 ] in plasma. [28] While evaluating the drugs for their benefi cial effects against MI, it is necessary to assess their effect on other vital organs like liver. Size of infarction can be measured by the sensitive indices of MI such as plasma transaminases, CK and LDH. [29] In ISO-administered rats, the increased activities of plasma transaminases, CK and LDH accompanied by their concomitant reduction in the heart homogenate [ Table 3 ] confi rm the onset of oxidative damage. The signifi cant decrease of marker enzymes in the plasma in pretreated group compared to ISO-administered group suggests that NMAET prevents the damage induced by ISO and hence avoids leakage of marker enzymes. High levels of GGT and transaminases have been associated in populations with increased risk of atherosclerotic CVD. [30] GGT is one of the enzymes used to monitor the liver damage. Signifi cant (P < 0.05) elevation of plasma GGT in ISO-administered rats confi rms damage and injury to the hepatocytes.
Present study is in accordance with earlier reported study, [31] which has shown that the amount of diagnostic markers present in plasma is directly proportional to the number of necrotic cells present in the cardiac tissue. Cytosolic macromolecules like enzymes, proteins and polysaccharides leak from the necrotic myocardium and hepatocytes. These molecules because of their tissue specifi city and catalytic activity are the best indicators of cardiac and hepatic damage. Increased release of these markers into systemic circulation observed in the present study refl ects nonspecific alterations in the hepatic and myocardial membrane integrity and permeability as a response to β Plasma adrenergic stimulation. [32] NMAET pretreatment decreased the activities of these marker enzymes in ISO-administered rats, this could be due to the FR scavenging property of the extract in the presence of antioxidative phytochemicals such as fl avonoids, alkaloids, and especially by myristicin. Hepatoprotective effect of myristicin from nutmeg on lipopolysaccharide/D-galactosamine-induced liver injury was experimentally evident, [33] and the same has been proven by our in vitro FR scavenging activity and inhibition of LPO [ Figure 2 ] by the NMAET. This fi nding strongly supports NMAET as a hepatoprotective protective agent. Thus, rats pretreated with NMAET showed cardioprotective activity which is evidenced by signifi cant restoration of activities of myocardial CK along with other marker enzymes.
FR scavenging enzymes such as CAT, SOD, GPx, and GST are the fi rst-line cellular defense against oxidative injury, decomposing O -2 and H 2 O 2 before interacting to form the more reactive hydroxyl radical. The equilibrium between these enzymes and ROS is an important process for the effective removal of oxidative stress in intracellular organelles. The second line of defense consists of the nonenzymatic scavengers viz. ascorbic acid, α-tocopherol, ceruloplasmin, and sulfhydryl containing compounds, which scavenge residual FR that escapes decomposition by the antioxidant enzymes. Our results demonstrate that ISO administration reduced the content of protein sulfhydryl group and GSH in cardiac tissue and this observation is in agreement with earlier fi ndings, [34] and the decreased activity of GPx and GST in ISO-administered group might be correlated to decreased availability of its substrate, GSH.
The data obtained in this study show remarkable decrease in the concentration of DPPH due to scavenging ability of NMAET. The FR scavenging activity was gradually increased with increase in concentration of NMAET from 50 to 600 μg/mL. The results indicated the noticeable effect of NMAET on scavenging DPPH FR in a dose-dependent manner. Based on the data obtained from this study, NMAET is a powerful FR inhibitor or scavenger, as well as a primary antioxidant that reacts with FR, which may limit FR damage. Scavenging of DPPH radical is related to the inhibition of LPO. [35] The extract was found to inhibit lipid peroxides generated by the induction of Fe 3 +/ADP/ascorbate in a dose-dependent manner as presented in the Table 1 . FR formed as a byproduct of many biochemical reactions (electron transport chain, catabolic steps in mitochondria, microsomal reactions, etc) initiate this phenomenon in a chain reaction. FR-induced LPO has gained much importance because of its involvement in several pathologies such as aging, atherosclerosis. [36] Due to the decreased antioxidant enzyme activities, the FR is not neutralized and hence myocardium shows enhanced susceptibility to LPO in the presence of promoters of LPO. However, NMAET pretreatment and treatment prevented the decrease in antioxidants and antioxidant enzyme levels [ Table 4 ]. A signifi cant (P < 0.05) decrease in myocardial SOD and GPx activity is observed in ISO administered rats when compared to control group. Our results are in agreement with previously reported studies. [37] Elevated LPO is an important pathogenic event in oxidative stress and in various diseases. ISO-induced generation of FR and ROS cause damage to the heart which is evident from the signifi cant (P < 0.05) increase in LPO in the heart tissue and plasma [ Figure 2 ] of ISO-administered rats indicating a state of oxidative stress. Pretreatment with NMAET in ISO administered rats reduced the levels of LPO in both heart tissue and plasma when compared with ISO alone administered rats suggesting its antioxidative and FR scavenging activity. In NMAET alone treated rats, the levels of LPO were lowered than the control rats which supports the scavenging action of extract. The postulated mechanisms including myocardial necrosis and apoptosis as well as FR generation may contribute to the pathogenesis of catecholamine-induced MI. [38] An imbalance between prooxidant and antioxidant levels in the body gives rise to cellular oxidative stress that plays an important role in the pathophysiology of the disease. [39] We found that the pronounced oxidative stress effect of ISO was signifi cantly reduced with NMAET. Moreover, NMAET treatment increases antioxidant enzyme status as compared with the control group. These fi ndings proved not only an antioxidant property of extract but it also clearly improved "the endogenous antioxidant reserve." The enhancement effect of NMAET on antioxidant activity has been reported for the fi rst time in our study, and our results are in agreement with in vitro studies. [40] Increased antioxidant status and decreased LPO are probably due to the presence of the isoprenoid unit in the structure of terpinene-4-ol and myristicin present in the NMAET. The unpaired electron present in the O -2 and H 2 O 2 generated during ISO-induced toxicity might have been trapped for dismutation by its FR scavenging isoprenoid unit.
Terpinene-4-ol is lipophilic in nature could be compared with any other lipophilic agent such as vitamin E, antipyrin, and nifedine in exerting membrane stabilizing action. Hence, it is possible that terpinene-4-ol likewise protects cell membranes from necrotic damage by its membrane stabilizing action. Similar results were reported by Senthil et al., [27] who carried out the protective effect of oleanolic acid.
Histopathological sections of liver [ Figure 3 ] showed increased tissue damage in ISO alone administered rats, whereas the damage is very much minimized in NMAET pretreatment. Histopatological study of liver from the control group animals showed a normal hepatic architecture with distinct hepatic cells, sinusoidal spaces, and a central vein. However, ISO-administered rats exhibited severe histopathological changes, such as centrilobular hepatic necrosis, fatty change, apoptotic bodies, and ballooning degeneration [ Figure 3 ]. Pretreatment with 100 mg of NMAET showed signifi cant recovery, from ballooning degeneration, fatty change, centrilobular hepatic necrosis, and also apoptotic bodies were scarce. This could be due to the hepatoprotective property of fl avonoids present in NMAET and this is in accordance with earlier reports of Morita et al. [33] The liver tissue sections of NMAET-treated animals [ Figure 3 ] showed no change in structure and are similar to that of the control group, indicating that NMAET is free from toxicity and an effective hepatoprotective agent. Limitation of the study includes lack of assessment between conventionally used hepatotoxicants like CCl 4 and paracetamol with that of ISO-induced hepatotocxicity.
CONCLUSION
Nutmeg has been shown to possess wide range of medicinal values in ayurveda and unani system of medicine. The organic extract of the nutmeg is used as anti-infl ammatory, diuretic and mimics insulin activity. The present communication is an endeavor in the direction of evaluating its antioxidant and hepatic protection against ISO-induced oxidative damage in rats. Thus, it is concluded that NMAET protects experimental hepatic injury as revealed by the amelioration of marker enzymes along with hepatoprotective effect, without any clinical complications as shown by oral toxicity studies. Overall results obtained in this study reveal that NMAET being cardioprotective agent also protects liver injury in MI induced by ISO associated oxidative stress. Hence, it can be used as a value-added pharmacological agent for managing risks associated with hepatic pathophysiology.
